Henoch S. Hong

1.8k total citations · 1 hit paper
22 papers, 963 citations indexed

About

Henoch S. Hong is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Henoch S. Hong has authored 22 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Virology and 7 papers in Molecular Biology. Recurrent topics in Henoch S. Hong's work include Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (6 papers) and Reproductive System and Pregnancy (5 papers). Henoch S. Hong is often cited by papers focused on Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (6 papers) and Reproductive System and Pregnancy (5 papers). Henoch S. Hong collaborates with scholars based in Germany, United States and Switzerland. Henoch S. Hong's co-authors include Sven D. Koch, Ulrike Gnad-Vogt, Reinhold E. Schmidt, Mariola Fotin‐Mleczek, Nupur Bhatnagar, Ingmar Hoerr, Linus Backert, Greg Finak, Martin Alberer and Keyvan Tadjalli Mehr and has published in prestigious journals such as Cell, The Lancet and Blood.

In The Last Decade

Henoch S. Hong

22 papers receiving 938 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

2017 373 citations Martin Alberer, Ulrike Gnad-Vogt et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henoch S. Hong Germany	14	577	335	257	151	126	22	963
Gustaf Lindgren Sweden	9	438 0.8×	344 1.0×	239 0.9×	84 0.6×	84 0.7×	14	761
Marie J. Estcourt Australia	13	617 1.1×	228 0.7×	93 0.4×	97 0.6×	197 1.6×	25	927
Sebastian Ols Sweden	12	399 0.7×	366 1.1×	374 1.5×	50 0.3×	54 0.4×	20	867
Ulrike Gnad-Vogt Germany	11	496 0.9×	649 1.9×	279 1.1×	48 0.3×	257 2.0×	28	1.0k
You Suk Suh South Korea	12	468 0.8×	194 0.6×	111 0.4×	88 0.6×	161 1.3×	19	762
Pritesh Desai United States	18	533 0.9×	170 0.5×	190 0.7×	55 0.4×	139 1.1×	31	858
Gennadiy Zelinskyy Germany	24	1.1k 1.9×	145 0.4×	228 0.9×	226 1.5×	258 2.0×	42	1.4k
Mattias N.E. Forsell Sweden	21	661 1.1×	212 0.6×	387 1.5×	451 3.0×	51 0.4×	54	1.2k
Motohide Ichino Japan	15	448 0.8×	248 0.7×	89 0.3×	61 0.4×	93 0.7×	23	792
Kerrie J. Sandgren Australia	18	535 0.9×	175 0.5×	149 0.6×	148 1.0×	85 0.7×	30	844

Countries citing papers authored by Henoch S. Hong

Since Specialization

Citations

This map shows the geographic impact of Henoch S. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henoch S. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henoch S. Hong more than expected).

Fields of papers citing papers by Henoch S. Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henoch S. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henoch S. Hong. The network helps show where Henoch S. Hong may publish in the future.

Co-authorship network of co-authors of Henoch S. Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Henoch S. Hong. A scholar is included among the top collaborators of Henoch S. Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henoch S. Hong. Henoch S. Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morfouace, Marie, Daniel Schulz, Nils Eling, et al.. (2023). 2266P IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort. Annals of Oncology. 34. S1164–S1164. 2 indexed citations

Hong, Henoch S., et al.. (2021). Yes, IMMUcan! Unraveling the human tumor microenvironment. 2(5). 301–309. 1 indexed citations

Mustapha, Rami, Valentina Pomella, José M. Vicencio, et al.. (2020). Abstract 4281: Overcoming preanalytical variabilities for peripheral blood mononuclear cells and exosome profiling in the IMMUcan multicentre study. Cancer Research. 80(16_Supplement). 4281–4281. 1 indexed citations

Elst, A. van der, Marie Morfouace, Henoch S. Hong, Robin Liechti, & J-P. Machiels. (2020). 97TiP Identification of therapeutic targets in patients with squamous cell carcinoma of the head and neck who progress on or after anti-PD-(L)1 therapy: An IMMUcan sub-project. Annals of Oncology. 31. S1455–S1456. 1 indexed citations

Doener, Fatma, Henoch S. Hong, Ingo Meyer, et al.. (2019). RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial. Vaccine. 37(13). 1819–1826. 37 indexed citations

Collins, Patrick L., Marina Cella, Sofia I. Porter, et al.. (2018). Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 176(1-2). 348–360.e12. 117 indexed citations

Stenzl, Arnulf, Isabel Syndikus, Tomasz Sarosiek, et al.. (2017). Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 28. v408–v409. 32 indexed citations

Alberer, Martin, Ulrike Gnad-Vogt, Henoch S. Hong, et al.. (2017). Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. The Lancet. 390(10101). 1511–1520. 373 indexed citations breakdown →

Hong, Henoch S., Sven D. Koch, Birgit Scheel, et al.. (2016). Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. OncoImmunology. 5(12). e1249560–e1249560. 18 indexed citations

10.

Eberhard, Johanna M., Fareed Ahmad, Henoch S. Hong, et al.. (2016). Partial recovery of senescence and differentiation disturbances in CD8+ T cell effector-memory cells in HIV-1 infection after initiation of anti-retroviral treatment. Clinical & Experimental Immunology. 186(2). 227–238. 7 indexed citations

11.

Billingsley, James M., Premeela A. Rajakumar, Michelle Connole, et al.. (2015). Characterization of CD8<sup>+</sup> T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling. Insecta mundi. 36 indexed citations

12.

Heidenreich, Regina, Keyvan Tadjalli Mehr, Sven D. Koch, et al.. (2015). RNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P163–P163. 2 indexed citations

13.

Koch, Sven D., Henoch S. Hong, Susan Feyerabend, et al.. (2014). A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P85–P85. 5 indexed citations

14.

Ahmad, Fareed, Henoch S. Hong, Alexandra Dopfer‐Jablonka, et al.. (2014). High Frequencies of Polyfunctional CD8⁺NK Cells in Chronic HIV-1 Infection Are Associated with Slower Disease Progression. Journal of Virology. 88(21). 12397–12408. 49 indexed citations

15.

Bhatnagar, Nupur, Fareed Ahmad, Henoch S. Hong, et al.. (2014). FcγRIII (CD16)‐mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32). European Journal of Immunology. 44(11). 3368–3379. 42 indexed citations

16.

Hong, Henoch S., Premeela A. Rajakumar, James M. Billingsley, R. Keith Reeves, & R. Paul Johnson. (2013). No monkey business: why studying NK cells in non-human primates pays off. Frontiers in Immunology. 4. 37 indexed citations

17.

Hong, Henoch S., Fareed Ahmad, Johanna M. Eberhard, et al.. (2012). Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load. PLoS ONE. 7(9). e44820–e44820. 29 indexed citations

18.

Hong, Henoch S., Johanna M. Eberhard, Fareed Ahmad, et al.. (2010). Phenotypically and functionally distinct subsets contribute to the expansion of CD56−/CD16+ natural killer cells in HIV infection. AIDS. 24(12). 1823–1834. 37 indexed citations

19.

Bhatnagar, Nupur, Henoch S. Hong, Jayendra Kumar Krishnaswamy, et al.. (2010). Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood. 116(8). 1308–1316. 54 indexed citations

20.

Hong, Henoch S., Johanna M. Eberhard, Matthias Ballmaier, et al.. (2009). HIV Infection Is Associated with a Preferential Decline in Less-Differentiated CD56^dimCD16⁺NK Cells. Journal of Virology. 84(2). 1183–1188. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact